KEVIN PEREZ: Open Payments
NPI 1851940381 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 12 payments from 10 companies in 2025. Trend: 2023 $1,767 · 2024 $647 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Genentech, Inc. | 1 | $139 |
| Ionis Pharmaceuticals, Inc. | 2 | $53 |
| Novo Nordisk Inc | 2 | $48 |
| BioCryst US Sales Co., LLC | 1 | $33 |
| ABBVIE INC. | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Phadia US Inc. | 1 | $14 |
Products named: Xolair, DAWNZERA, ORLADEYO, LINZESS, THINPREP 2000 PROCESSOR, OPDIVO, GARDASIL 9, Ozempic.
Industry payments across FL — which companies pay providers there.
